
Mizuho Medy Co Ltd
TSE:4595

Mizuho Medy Co Ltd
Inventory
Mizuho Medy Co Ltd
Inventory Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
Company | Inventory | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
---|---|---|---|---|---|---|
![]() |
Mizuho Medy Co Ltd
TSE:4595
|
Inventory
ÂĄ2B
|
CAGR 3-Years
17%
|
CAGR 5-Years
12%
|
CAGR 10-Years
N/A
|
|
![]() |
Terumo Corp
TSE:4543
|
Inventory
ÂĄ309B
|
CAGR 3-Years
18%
|
CAGR 5-Years
16%
|
CAGR 10-Years
11%
|
|
![]() |
Olympus Corp
TSE:7733
|
Inventory
ÂĄ197.1B
|
CAGR 3-Years
6%
|
CAGR 5-Years
3%
|
CAGR 10-Years
5%
|
|
![]() |
Sysmex Corp
TSE:6869
|
Inventory
ÂĄ91B
|
CAGR 3-Years
13%
|
CAGR 5-Years
12%
|
CAGR 10-Years
10%
|
|
![]() |
Nihon Kohden Corp
TSE:6849
|
Inventory
ÂĄ61B
|
CAGR 3-Years
10%
|
CAGR 5-Years
15%
|
CAGR 10-Years
11%
|
|
![]() |
JEOL Ltd
TSE:6951
|
Inventory
ÂĄ84.3B
|
CAGR 3-Years
9%
|
CAGR 5-Years
8%
|
CAGR 10-Years
7%
|
Mizuho Medy Co Ltd
Glance View
Mizuho Medy Co., Ltd. engages in the research, development, manufacture and distribution of in-vitro diagnostic products. The company is headquartered in Tosu-Shi, Saga-Ken and currently employs 173 full-time employees. The company went IPO on 2015-12-17. The firm mainly provides in-vitro diagnostic pharmaceuticals, including immune serum test drugs, biochemical test drugs, urine and feces test drugs, microbial test drugs, blood test drugs, pathological test drugs and others, in hospital and medical practitioner fields. In addition, the Company also provides over-the-counter (OTC) drugs to pharmacies and drug stores, and sells fruit tree virus test drugs to which they apply the technology of immune serology test to agricultural test centers.

See Also
What is Mizuho Medy Co Ltd's Inventory?
Inventory
2B
JPY
Based on the financial report for Dec 31, 2024, Mizuho Medy Co Ltd's Inventory amounts to 2B JPY.
What is Mizuho Medy Co Ltd's Inventory growth rate?
Inventory CAGR 5Y
12%
Over the last year, the Inventory growth was 28%. The average annual Inventory growth rates for Mizuho Medy Co Ltd have been 17% over the past three years , 12% over the past five years .